• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Study Highlights Diabetes Sleep Apnea Relationship

November 15, 2013 by admin

Acknowledging “a growing body of research” linking sleep apnea and Type 2 diabetes, a story by author Valerie Lauer reports that primary care physicians are increasingly identifying and treating OSA as an insulin-impacting comorbidity.

Though the connection between Type 2 diabetes and OSA is not fully understood, some small-scale studies, such as one published last year by University of Chicago researchers, suggest restricted or frequently interrupted sleep can cause lipocytes and fat cells to become more insulin resistant, a precursor of Type 2 diabetes.

“The main thing with treatment of diabetes is to minimize the effects of comorbid conditions,” says Alvah R. Cass, MD, SM, Professor of Family Medicine with The University of Texas Medical Branch. “OSA appears to be emerging as one of those modifiable conditions, and if we were to pay attention to it, recognize it and treat it, we might have better outcomes associated with diabetes, as well as OSA.”

Lauer reports that Cass is the main author of a study initiated by W. Jerome Alonso, MD, that appeared earlier in 2013 in the Family Medicine Journal – The Society of Teachers of Family Medicine “Risk of Obstructive Sleep Apnea in Patients With Type 2 Diabetes Mellitus“. The study used several low-cost methods, most notably the Berlin Questionnaire, to assess the OSA risk of 297 patients with Type 2 diabetes from three broad ethnic groups.

Despite the prevalence of OSA — an estimated 12 million adults in the United States have the condition — and its shared risk factors with Type 2 diabetes, only 37 participants had been diagnosed with OSA prior to joining the study. After answering the Berlin Questionnaire, almost half of the remaining participants were found to be at high risk for OSA.

Full article available here 

Source: MD News

Filed Under: Articles, Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy